From laboratory to clinic: science commercialization within university‐centered entrepreneurial ecosystems

D Johnson, PT Gianiodis, RT Harrison… - R&D …, 2023 - Wiley Online Library
The commercialization of scientific discoveries within the university‐industry nexus is
multifaceted and complex, characterized by dynamic interactions between multiple agents …

[HTML][HTML] Ethics of Early Clinical Trials of Bio-Artificial Organs

EM Bunnik, D De Jongh, E Massey - 2022 - frontierspartnerships.org
Regenerative medicine is the new frontier in the field of organ transplantation. Research
groups around the world are using regenerative medicine technologies to develop bio …

Partnership agreements for regenerative medicines: a database analysis and implications for future innovation

T Qiu, Y Wang, S Liang, R Han, M Toumi - Regenerative Medicine, 2021 - Taylor & Francis
Aim: Partnerships have been leveraged to advance the regenerative medicines (RMs)
development. This study analyzed the evolution of partnership landscape for regenerative …

An Ethical Perspective on the Social Value of Cell-Based Technologies in Type 1 Diabetes

D de Jongh, EM Bunnik - Pluripotent Stem Cell Therapy for Diabetes, 2024 - Springer
Regenerative medicine is set to revolutionize the treatment of type 1 diabetes. Using cell-
based technologies, it seeks to restore within the patient's body the function of pancreatic …

[图书][B] Regenerative Medicine: Unlocking Patient Access and Commercial Potential

T Qiu, M Toumi - 2023 - taylorfrancis.com
A comprehensive review of the challenges that exist in patient accessibility to regenerative
medicines (RMs), presenting clinical trials, marketing authorization, HTA, pricing …